Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor

Biochemical and Biophysical Research Communications
P SethV Ganapathy

Abstract

We have isolated a mouse cDNA which codes for a functional type 1 sigma receptor. The functional identity of the cDNA was established by expressing the cDNA in mammalian cells and measuring the cDNA-induced binding of haloperidol. Using this cDNA as the probe, we have isolated a murine genomic clone which contains the type 1 sigma receptor gene in its entirety. We have sequenced the gene completely, deduced the exon-intron organization and analyzed the promoter region sequence for transcription factor binding sites. The gene (approximately 7 kbp) is TATA-less but contains CCAATC and GC boxes immediately upstream of the transcription start site. The gene consists of 4 exons and 3 introns. The 5'-flanking region contains putative binding sites for AP-1, AP-2, GATA-1 and steroid receptors.

Citations

Nov 1, 2001·Brain Research. Molecular Brain Research·M S OlaS B Smith
Apr 6, 2002·British Journal of Pharmacology·Anis KlouzDidier Morin
May 25, 2002·The European Journal of Neuroscience·Vân-Ly PhanTangui Maurice
Mar 21, 2002·Fundamental & Clinical Pharmacology·Laurent Monassier, Pascal Bousquet
Feb 19, 2008·Neuroreport·Melanie A PaquetteStephen Paul Berger
Nov 19, 2010·American Journal of Physiology. Cell Physiology·Molly JohannessenMeyer B Jackson
Mar 13, 2009·American Journal of Physiology. Cell Physiology·Molly JohannessenMeyer B Jackson
May 13, 2008·Investigative Ophthalmology & Visual Science·Sylvia B SmithVadivel Ganapathy
Mar 25, 2011·Future Medicinal Chemistry·Sanju NarayananChristopher R McCurdy
Jan 6, 2011·Expert Opinion on Therapeutic Targets·Md Shenuarin Bhuiyan, Kohji Fukunaga
Jun 4, 2015·Expert Opinion on Drug Discovery·Mellar P Davis
Dec 9, 2015·Current Eye Research·Arul K ShanmugamSylvia B Smith
Aug 23, 2012·Journal of Pharmaceutical and Biomedical Analysis·James A FishbackRae R Matsumoto
Jan 5, 2010·PET Clinics·Robert H MachKenneth T Wheeler
Nov 19, 2003·The European Journal of Neuroscience·Francina LangaLluís Montoliu
Aug 19, 2011·Chemical Biology & Drug Design·Mine YarimBernard Wünsch
Aug 8, 2013·Medicinal Research Reviews·Yun-Sheng HuangZongwen Wu
Oct 7, 2004·Neuropharmacology·Gavril W Pasternak
Oct 16, 2014·Molecular Neurobiology·Shigeki MoriguchiKohji Fukunaga
May 26, 2015·European Journal of Pharmacology·John R LeverEmily A Fergason-Cantrell
Dec 7, 2010·European Journal of Pharmacology·James A FishbackRae R Matsumoto
Mar 13, 2010·Neuroscience·L L LiuX L Yang
Dec 14, 2007·Expert Opinion on Therapeutic Targets·Teruo Hayashi, Tsung-Ping Su
Jun 10, 2015·Journal of Receptor and Signal Transduction Research·Colin G Rousseaux, Stephanie F Greene
Feb 23, 2013·Journal of Pharmacological Sciences·Md Shenuarin BhuiyanKohji Fukunaga
Feb 25, 2010·Neuropharmacology·Taro KishiNakao Iwata

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here